$NVIV Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in INVIVO THERAPEUTICS HOLDINGS CORP..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in INVIVO THERAPEUTICS HOLDINGS CORP.. Get notifications about new insider transactions in INVIVO THERAPEUTICS HOLDINGS CORP. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 22 2021 | NVIV | INVIVO THERAPEUTIC ... | ROSENTHAL BOB | Director | Option Exercise | A | 1.10 | 15,000 | 16,500 | 15,000 | |
Mar 22 2021 | NVIV | INVIVO THERAPEUTIC ... | MERRIFIELD C ANN | Director | Option Exercise | A | 1.10 | 15,000 | 16,500 | 15,000 | |
Mar 22 2021 | NVIV | INVIVO THERAPEUTIC ... | CHRISTOPHER RICHARD | CFO and Treasurer | Option Exercise | A | 1.10 | 75,000 | 82,500 | 75,000 | |
Mar 22 2021 | NVIV | INVIVO THERAPEUTIC ... | Toselli Richard M. | See Remarks | Option Exercise | A | 1.10 | 150,000 | 165,000 | 150,000 | |
Mar 22 2021 | NVIV | INVIVO THERAPEUTIC ... | MARSHAK DANIEL R | Director | Option Exercise | A | 1.10 | 15,000 | 16,500 | 15,000 | |
Mar 22 2021 | NVIV | INVIVO THERAPEUTIC ... | Morrison Christina | Director | Option Exercise | A | 1.10 | 15,000 | 16,500 | 15,000 | |
Mar 22 2021 | NVIV | INVIVO THERAPEUTIC ... | ROBERTS RICHARD JOHN | Director | Option Exercise | A | 1.10 | 15,000 | 16,500 | 15,000 | |
Dec 23 2020 | NVIV | INVIVO THERAPEUTIC ... | Toselli Richard M. | See Remarks | Payment of Exercise | F | 0.60 | 16 | 10 | 6,238 | 6.3 K to 6.2 K (-0.26 %) |
Jun 23 2020 | NVIV | INVIVO THERAPEUTIC ... | Toselli Richard M. | See Remarks | Payment of Exercise | F | 1.70 | 15 | 26 | 6,054 | 6.1 K to 6.1 K (-0.25 %) |
Mar 12 2020 | NVIV | INVIVO THERAPEUTIC ... | Toselli Richard M. | See Remarks | Option Exercise | P | 2.75 | 3,636 | 9,999 | 3,636 | |
Mar 12 2020 | NVIV | INVIVO THERAPEUTIC ... | Toselli Richard M. | See Remarks | Buy | P | 0.00 | 3,636 | 0 | 6,069 | 2.4 K to 6.1 K (+149.45 %) |
Mar 12 2020 | NVIV | INVIVO THERAPEUTIC ... | CHRISTOPHER RICHARD | CFO and Treasurer | Option Exercise | P | 2.75 | 3,636 | 9,999 | 3,636 | |
Mar 12 2020 | NVIV | INVIVO THERAPEUTIC ... | CHRISTOPHER RICHARD | CFO and Treasurer | Buy | P | 0.00 | 3,636 | 0 | 5,220 | 1.6 K to 5.2 K (+229.55 %) |
Mar 12 2020 | NVIV | INVIVO THERAPEUTIC ... | MERRIFIELD C ANN | Director | Option Exercise | P | 2.75 | 3,636 | 9,999 | 3,636 | |
Mar 12 2020 | NVIV | INVIVO THERAPEUTIC ... | MERRIFIELD C ANN | Director | Buy | P | 0.00 | 3,636 | 0 | 3,639 | 3 to 3.6 K (+121,200.00 %) |
Dec 23 2019 | NVIV | INVIVO THERAPEUTIC ... | Toselli Richard M. | See Remarks | Payment of Exercise | F | 0.16 | 557 | 89 | 78,986 | 79.5 K to 79 K (-0.70 %) |
Sep 27 2019 | NVIV | INVIVO THERAPEUTIC ... | Toselli Richard M. | See Remarks | Sell | S | 0.97 | 5,229 | 5,072 | 0 | 5.2 K to 0 (-100.00 %) |
Sep 27 2019 | NVIV | INVIVO THERAPEUTIC ... | Toselli Richard M. | See Remarks | Sell | S | 0.97 | 5,229 | 5,072 | 0 | 5.2 K to 0 (-100.00 %) |
Sep 27 2019 | NVIV | INVIVO THERAPEUTIC ... | Toselli Richard M. | See Remarks | Grant | A | 0.00 | 69,000 | 0 | 79,543 | 10.5 K to 79.5 K (+654.46 %) |
Sep 27 2019 | NVIV | INVIVO THERAPEUTIC ... | Toselli Richard M. | See Remarks | Grant | A | 0.00 | 69,000 | 0 | 79,543 | 10.5 K to 79.5 K (+654.46 %) |
Sep 27 2019 | NVIV | INVIVO THERAPEUTIC ... | CHRISTOPHER RICHARD | CFO and Treasurer | Grant | A | 0.00 | 47,500 | 0 | 47,500 | 0 to 47.5 K |
Jun 21 2019 | NVIV | INVIVO THERAPEUTIC ... | Toselli Richard M. | See Remarks | Payment of Exercise | F | 0.75 | 72 | 54 | 10,543 | 10.6 K to 10.5 K (-0.68 %) |
May 22 2019 | NVIV | INVIVO THERAPEUTIC ... | Toselli Richard M. | See Remarks | Payment of Exercise | F | 1.10 | 78 | 86 | 10,615 | 10.7 K to 10.6 K (-0.73 %) |
Apr 24 2019 | NVIV | INVIVO THERAPEUTIC ... | Toselli Richard M. | See Remarks | Payment of Exercise | F | 1.45 | 79 | 115 | 10,693 | 10.8 K to 10.7 K (-0.73 %) |
Mar 20 2019 | NVIV | INVIVO THERAPEUTIC ... | Toselli Richard M. | See Remarks | Payment of Exercise | F | 1.53 | 78 | 119 | 10,772 | 10.9 K to 10.8 K (-0.72 %) |
Feb 20 2019 | NVIV | INVIVO THERAPEUTIC ... | Toselli Richard M. | See Remarks | Payment of Exercise | F | 1.41 | 95 | 134 | 10,850 | 10.9 K to 10.9 K (-0.87 %) |
Jan 22 2019 | NVIV | INVIVO THERAPEUTIC ... | Toselli Richard M. | See Remarks | Payment of Exercise | F | 1.58 | 94 | 149 | 10,945 | 11 K to 10.9 K (-0.85 %) |
Jan 22 2019 | NVIV | INVIVO THERAPEUTIC ... | Toselli Richard M. | See Remarks | Payment of Exercise | F | 1.58 | 94 | 149 | 10,945 | 11 K to 10.9 K (-0.85 %) |
Jan 16 2019 | NVIV | INVIVO THERAPEUTIC ... | CHRISTOPHER RICHARD | CFO and Treasurer | Option Exercise | A | 1.53 | 90,000 | 137,700 | 90,000 | |
Jan 16 2019 | NVIV | INVIVO THERAPEUTIC ... | CHRISTOPHER RICHARD | CFO and Treasurer | Option Exercise | A | 1.53 | 90,000 | 137,700 | 90,000 | |
Dec 20 2018 | NVIV | INVIVO THERAPEUTIC ... | Toselli Richard M. | See Remarks | Payment of Exercise | F | 1.69 | 961 | 1,624 | 11,039 | 12 K to 11 K (-8.01 %) |
Dec 20 2018 | NVIV | INVIVO THERAPEUTIC ... | Toselli Richard M. | See Remarks | Grant | A | 0.00 | 12,000 | 0 | 12,000 | 0 to 12 K |
Jan 23 2018 | NVIV | INVIVO THERAPEUTIC ... | Morrison Christina | Director | Option Exercise | A | 0.69 | 12,500 | 8,625 | 12,500 | |
Jan 23 2018 | NVIV | INVIVO THERAPEUTIC ... | ROBERTS RICHARD JOHN | Director | Option Exercise | A | 0.69 | 12,500 | 8,625 | 12,500 | |
Jan 23 2018 | NVIV | INVIVO THERAPEUTIC ... | MARSHAK DANIEL R | Director | Option Exercise | A | 0.69 | 12,500 | 8,625 | 12,500 | |
Jan 23 2018 | NVIV | INVIVO THERAPEUTIC ... | MERRIFIELD C ANN | Director | Option Exercise | A | 0.69 | 12,500 | 8,625 | 12,500 | |
Jan 23 2018 | NVIV | INVIVO THERAPEUTIC ... | DiPietro Kenneth | Director | Option Exercise | A | 0.69 | 12,500 | 8,625 | 12,500 | |
Jan 23 2018 | NVIV | INVIVO THERAPEUTIC ... | Hatfield Jeffrey S. | Director | Option Exercise | A | 0.69 | 12,500 | 8,625 | 12,500 | |
Jul 07 2017 | NVIV | INVIVO THERAPEUTIC ... | Toselli Richard M. | Chief Medical Offic ... | Option Exercise | A | 2.55 | 325,000 | 828,750 | 325,000 | |
Apr 20 2017 | NVIV | INVIVO THERAPEUTIC ... | ROBERTS RICHARD JOHN | Director | Option Exercise | M | 0.29 | 30,984 | 8,998 | 0 | |
Apr 20 2017 | NVIV | INVIVO THERAPEUTIC ... | ROBERTS RICHARD JOHN | Director | Buy | M | 0.29 | 30,984 | 8,998 | 216,887 | 185.9 K to 216.9 K (+16.67 %) |
Mar 31 2017 | NVIV | INVIVO THERAPEUTIC ... | McNulty Christopher | Chief Financial Off ... | Option Exercise | A | 4.00 | 29,973 | 119,892 | 29,973 | |
Feb 17 2017 | NVIV | INVIVO THERAPEUTIC ... | ROBERTS RICHARD JOHN | Director | Option Exercise | M | 0.29 | 58,403 | 16,960 | 0 | |
Feb 17 2017 | NVIV | INVIVO THERAPEUTIC ... | ROBERTS RICHARD JOHN | Director | Buy | M | 0.29 | 58,403 | 16,960 | 185,903 | 127.5 K to 185.9 K (+45.81 %) |
Jan 23 2017 | NVIV | INVIVO THERAPEUTIC ... | MARSHAK DANIEL R | Director | Option Exercise | A | 4.35 | 12,500 | 54,375 | 12,500 | |
Jan 23 2017 | NVIV | INVIVO THERAPEUTIC ... | MERRIFIELD C ANN | Director | Option Exercise | A | 4.35 | 12,500 | 54,375 | 12,500 | |
Jan 23 2017 | NVIV | INVIVO THERAPEUTIC ... | Morrison Christina | Director | Option Exercise | A | 4.35 | 12,500 | 54,375 | 12,500 | |
Jan 23 2017 | NVIV | INVIVO THERAPEUTIC ... | ROBERTS RICHARD JOHN | Director | Option Exercise | A | 4.35 | 12,500 | 54,375 | 12,500 | |
Jan 23 2017 | NVIV | INVIVO THERAPEUTIC ... | DiPietro Kenneth | Director | Option Exercise | A | 4.35 | 12,500 | 54,375 | 12,500 | |
Jan 20 2017 | NVIV | INVIVO THERAPEUTIC ... | JOSEPH TAMARA L | SVP, General Counse ... | Option Exercise | A | 4.35 | 120,000 | 522,000 | 120,000 | |
Jan 20 2017 | NVIV | INVIVO THERAPEUTIC ... | STAHL PAMELA J | Chief Commercial Of ... | Option Exercise | A | 4.35 | 35,000 | 152,250 | 35,000 | |
Jan 20 2017 | NVIV | INVIVO THERAPEUTIC ... | PERRIN MARK D | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 4.35 | 320,000 | 1,392,000 | 320,000 | |
Jan 20 2017 | NVIV | INVIVO THERAPEUTIC ... | Ulich Thomas R | Chief Scientific Of ... | Option Exercise | A | 4.35 | 150,000 | 652,500 | 150,000 | |
Nov 03 2016 | NVIV | INVIVO THERAPEUTIC ... | Hatfield Jeffrey S. | Director | Option Exercise | A | 4.25 | 25,000 | 106,250 | 25,000 | |
Sep 16 2016 | NVIV | INVIVO THERAPEUTIC ... | STAHL PAMELA J | Chief Commercial Of ... | Option Exercise | A | 6.47 | 188,200 | 1,217,654 | 188,200 | |
Aug 23 2016 | NVIV | INVIVO THERAPEUTIC ... | ROBERTS RICHARD JOHN | Director | Option Exercise | M | 0.29 | 70,000 | 20,328 | 58,403 | |
Aug 23 2016 | NVIV | INVIVO THERAPEUTIC ... | ROBERTS RICHARD JOHN | Director | Buy | M | 0.29 | 70,000 | 20,328 | 127,500 | 57.5 K to 127.5 K (+121.74 %) |
Jun 09 2016 | NVIV | INVIVO THERAPEUTIC ... | Morrison Christina | Director | Option Exercise | A | 6.80 | 25,000 | 170,000 | 25,000 | |
Mar 08 2016 | NVIV | INVIVO THERAPEUTIC ... | ROBERTS RICHARD JOHN | Director | Option Exercise | M | 0.29 | 35,000 | 10,164 | 128,403 | |
Mar 08 2016 | NVIV | INVIVO THERAPEUTIC ... | ROBERTS RICHARD JOHN | Director | Option Exercise | M | 0.29 | 20,000 | 5,808 | 163,403 | |
Mar 08 2016 | NVIV | INVIVO THERAPEUTIC ... | ROBERTS RICHARD JOHN | Director | Buy | M | 0.29 | 35,000 | 10,164 | 65,000 | 30 K to 65 K (+116.67 %) |
Mar 08 2016 | NVIV | INVIVO THERAPEUTIC ... | ROBERTS RICHARD JOHN | Director | Buy | M | 0.29 | 20,000 | 5,808 | 30,000 | 10 K to 30 K (+200.00 %) |
Dec 11 2015 | NVIV | INVIVO THERAPEUTIC ... | Lorianne Masuoka K. | Chief Medical Offic ... | Option Exercise | A | 7.37 | 115,050 | 847,919 | 115,050 | |
Dec 11 2015 | NVIV | INVIVO THERAPEUTIC ... | JOSEPH TAMARA L | SVP, General Counse ... | Option Exercise | A | 7.37 | 92,040 | 678,335 | 92,040 | |
Dec 11 2015 | NVIV | INVIVO THERAPEUTIC ... | Ulich Thomas R | Chief Scientific Of ... | Option Exercise | A | 7.37 | 115,050 | 847,919 | 115,050 | |
Dec 11 2015 | NVIV | INVIVO THERAPEUTIC ... | MCALLISTER STEVEN F | Chief Financial Off ... | Option Exercise | A | 7.37 | 71,900 | 529,903 | 71,900 | |
Dec 11 2015 | NVIV | INVIVO THERAPEUTIC ... | PERRIN MARK D | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 7.37 | 172,570 | 1,271,841 | 172,570 | |
Dec 11 2015 | NVIV | INVIVO THERAPEUTIC ... | ROBERTS RICHARD JOHN | Director | Option Exercise | A | 7.37 | 12,500 | 92,125 | 12,500 | |
Dec 11 2015 | NVIV | INVIVO THERAPEUTIC ... | MCCARTHY JOHN A JR | Director | Option Exercise | A | 7.37 | 12,500 | 92,125 | 12,500 | |
Dec 11 2015 | NVIV | INVIVO THERAPEUTIC ... | MARSHAK DANIEL R | Director | Option Exercise | A | 7.37 | 12,500 | 92,125 | 12,500 | |
Dec 11 2015 | NVIV | INVIVO THERAPEUTIC ... | MERRIFIELD C ANN | Director | Option Exercise | A | 7.37 | 12,500 | 92,125 | 12,500 | |
Dec 11 2015 | NVIV | INVIVO THERAPEUTIC ... | DiPietro Kenneth | Director | Option Exercise | A | 7.37 | 12,500 | 92,125 | 12,500 | |
Aug 14 2015 | NVIV | INVIVO THERAPEUTIC ... | MERRIFIELD C ANN | Director | Buy | P | 12.36 | 2,000 | 24,718 | 2,000 | 0 to 2 K |
Aug 04 2015 | NVIV | INVIVO THERAPEUTIC ... | DiPietro Kenneth | Director | Option Exercise | A | 14.55 | 12,500 | 181,875 | 12,500 | |
Aug 04 2015 | NVIV | INVIVO THERAPEUTIC ... | MCCARTHY JOHN A JR | Director | Option Exercise | A | 14.55 | 12,500 | 181,875 | 12,500 | |
Aug 04 2015 | NVIV | INVIVO THERAPEUTIC ... | ROBERTS RICHARD JOHN | Director | Option Exercise | A | 14.55 | 12,500 | 181,875 | 12,500 | |
Aug 04 2015 | NVIV | INVIVO THERAPEUTIC ... | JOSEPH TAMARA L | SVP, General Counse ... | Option Exercise | A | 14.55 | 12,500 | 181,875 | 12,500 | |
Mar 04 2015 | NVIV | INVIVO THERAPEUTIC ... | Lorianne Masuoka K. | Chief Medical Offic ... | Option Exercise | A | 3.02 | 500,000 | 1,510,000 | 500,000 | |
Dec 11 2014 | NVIV | INVIVO THERAPEUTIC ... | MERRIFIELD C ANN | Director | Option Exercise | A | 1.05 | 50,000 | 52,500 | 50,000 | |
Dec 11 2014 | NVIV | INVIVO THERAPEUTIC ... | ROBERTS RICHARD JOHN | Director | Option Exercise | A | 1.05 | 50,000 | 52,500 | 50,000 | |
Dec 11 2014 | NVIV | INVIVO THERAPEUTIC ... | MCCARTHY JOHN A JR | Director | Option Exercise | A | 1.05 | 50,000 | 52,500 | 50,000 | |
Dec 11 2014 | NVIV | INVIVO THERAPEUTIC ... | MARSHAK DANIEL R | Director | Option Exercise | A | 1.05 | 50,000 | 52,500 | 50,000 | |
Dec 11 2014 | NVIV | INVIVO THERAPEUTIC ... | DiPietro Kenneth | Director | Option Exercise | A | 1.05 | 50,000 | 52,500 | 50,000 | |
Dec 11 2014 | NVIV | INVIVO THERAPEUTIC ... | PERRIN MARK D | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 1.05 | 500,000 | 525,000 | 500,000 | |
Dec 11 2014 | NVIV | INVIVO THERAPEUTIC ... | PERRIN MARK D | CHIEF EXECUTIVE OFF ... | Grant | A | 0.00 | 57,142 | 0 | 57,142 | 0 to 57.1 K |
Dec 11 2014 | NVIV | INVIVO THERAPEUTIC ... | Ulich Thomas R | Chief Scientific Of ... | Option Exercise | A | 1.05 | 325,000 | 341,250 | 325,000 | |
Dec 11 2014 | NVIV | INVIVO THERAPEUTIC ... | Ulich Thomas R | Chief Scientific Of ... | Grant | A | 0.00 | 21,428 | 0 | 21,428 | 0 to 21.4 K |
Dec 11 2014 | NVIV | INVIVO THERAPEUTIC ... | MCALLISTER STEVEN F | Chief Financial Off ... | Option Exercise | A | 1.05 | 62,500 | 65,625 | 62,500 | |
Dec 11 2014 | NVIV | INVIVO THERAPEUTIC ... | MCALLISTER STEVEN F | Chief Financial Off ... | Grant | A | 0.00 | 18,928 | 0 | 18,928 | 0 to 18.9 K |
Dec 11 2014 | NVIV | INVIVO THERAPEUTIC ... | JOSEPH TAMARA L | SVP, General Counse ... | Option Exercise | A | 1.05 | 137,500 | 144,375 | 137,500 | |
Dec 11 2014 | NVIV | INVIVO THERAPEUTIC ... | JOSEPH TAMARA L | SVP, General Counse ... | Grant | A | 0.00 | 15,428 | 0 | 15,428 | 0 to 15.4 K |
Nov 12 2014 | NVIV | INVIVO THERAPEUTIC ... | MERRIFIELD C ANN | Director | Option Exercise | A | 1.00 | 50,000 | 50,000 | 50,000 | |
Sep 30 2014 | NVIV | INVIVO THERAPEUTIC ... | MARSHAK DANIEL R | Director | Option Exercise | A | 0.59 | 50,000 | 29,500 | 50,000 | |
Aug 12 2014 | NVIV | INVIVO THERAPEUTIC ... | ROBERTS RICHARD JOHN | Director | Option Exercise | M | 0.07 | 10,000 | 726 | 733,612 | |
Aug 12 2014 | NVIV | INVIVO THERAPEUTIC ... | ROBERTS RICHARD JOHN | Director | Buy | M | 0.07 | 10,000 | 726 | 10,000 | 0 to 10 K |
Jun 19 2014 | NVIV | INVIVO THERAPEUTIC ... | MCALLISTER STEVEN F | Chief Financial Off ... | Option Exercise | A | 1.13 | 250,000 | 282,500 | 250,000 | |
May 09 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.20 | 12,500 | 15,000 | 9,045,920 | 9.1 M to 9 M (-0.14 %) |
May 09 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.19 | 12,500 | 14,875 | 9,058,420 | 9.1 M to 9.1 M (-0.14 %) |
May 09 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.20 | 25,000 | 30,000 | 9,070,920 | 9.1 M to 9.1 M (-0.27 %) |
May 01 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.89 | 12,500 | 23,625 | 9,120,920 | 9.1 M to 9.1 M (-0.14 %) |
May 01 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.82 | 12,500 | 22,750 | 9,133,420 | 9.1 M to 9.1 M (-0.14 %) |
May 01 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.76 | 12,500 | 22,000 | 9,145,920 | 9.2 M to 9.1 M (-0.14 %) |
May 06 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.79 | 21,200 | 37,948 | 9,083,420 | 9.1 M to 9.1 M (-0.23 %) |
May 06 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.05 | 3,800 | 7,790 | 9,095,920 | 9.1 M to 9.1 M (-0.04 %) |
May 06 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.95 | 12,500 | 24,375 | 9,108,420 | 9.1 M to 9.1 M (-0.14 %) |
Apr 25 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.51 | 12,500 | 18,875 | 9,158,420 | 9.2 M to 9.2 M (-0.14 %) |
Apr 25 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.51 | 12,500 | 18,875 | 9,170,920 | 9.2 M to 9.2 M (-0.14 %) |
Apr 25 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.52 | 12,500 | 19,000 | 9,183,420 | 9.2 M to 9.2 M (-0.14 %) |
Apr 25 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.52 | 12,500 | 19,000 | 9,195,920 | 9.2 M to 9.2 M (-0.14 %) |
Apr 21 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.57 | 12,500 | 19,625 | 9,208,420 | 9.2 M to 9.2 M (-0.14 %) |
Apr 21 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.55 | 12,500 | 19,375 | 9,220,920 | 9.2 M to 9.2 M (-0.14 %) |
Apr 21 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.57 | 12,500 | 19,625 | 9,233,420 | 9.2 M to 9.2 M (-0.14 %) |
Apr 21 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.57 | 12,500 | 19,625 | 9,245,920 | 9.3 M to 9.2 M (-0.14 %) |
Apr 15 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.62 | 12,500 | 20,250 | 9,258,420 | 9.3 M to 9.3 M (-0.13 %) |
Apr 15 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.63 | 12,500 | 20,375 | 9,270,920 | 9.3 M to 9.3 M (-0.13 %) |
Apr 15 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.64 | 12,500 | 20,500 | 9,283,420 | 9.3 M to 9.3 M (-0.13 %) |
Apr 09 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.55 | 12,500 | 19,375 | 9,295,920 | 9.3 M to 9.3 M (-0.13 %) |
Apr 09 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.62 | 12,500 | 20,250 | 9,308,420 | 9.3 M to 9.3 M (-0.13 %) |
Apr 09 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.62 | 12,500 | 20,250 | 9,320,920 | 9.3 M to 9.3 M (-0.13 %) |
Apr 07 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.70 | 12,500 | 21,250 | 9,333,420 | 9.3 M to 9.3 M (-0.13 %) |
Apr 07 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.72 | 12,500 | 21,500 | 9,345,920 | 9.4 M to 9.3 M (-0.13 %) |
Apr 03 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.68 | 12,500 | 21,000 | 9,358,420 | 9.4 M to 9.4 M (-0.13 %) |
Apr 03 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.70 | 12,500 | 21,250 | 9,370,920 | 9.4 M to 9.4 M (-0.13 %) |
Apr 03 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.74 | 12,500 | 21,750 | 9,383,420 | 9.4 M to 9.4 M (-0.13 %) |
Mar 28 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.76 | 12,500 | 22,000 | 9,398,920 | 9.4 M to 9.4 M (-0.13 %) |
Mar 28 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.75 | 12,500 | 21,875 | 9,411,420 | 9.4 M to 9.4 M (-0.13 %) |
Mar 26 2014 | NVIV | INVIVO THERAPEUTIC ... | Ulich Thomas R | Chief Scientific Of ... | Option Exercise | A | 2.33 | 350,000 | 815,500 | 350,000 | |
Mar 26 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.71 | 12,500 | 21,375 | 9,423,920 | 9.4 M to 9.4 M (-0.13 %) |
Mar 26 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.78 | 12,500 | 22,250 | 9,436,420 | 9.4 M to 9.4 M (-0.13 %) |
Mar 26 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.85 | 22,900 | 42,365 | 9,448,920 | 9.5 M to 9.4 M (-0.24 %) |
Mar 26 2014 | NVIV | INVIVO THERAPEUTIC ... | JOSEPH TAMARA L | SVP, General Counse ... | Option Exercise | A | 1.88 | 300,000 | 564,000 | 300,000 | |
Mar 17 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.48 | 12,500 | 31,000 | 9,661,420 | 9.7 M to 9.7 M (-0.13 %) |
Mar 17 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.47 | 12,500 | 30,875 | 9,673,920 | 9.7 M to 9.7 M (-0.13 %) |
Mar 17 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.37 | 12,500 | 29,625 | 9,686,420 | 9.7 M to 9.7 M (-0.13 %) |
Mar 17 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.48 | 12,500 | 31,000 | 9,661,420 | 9.7 M to 9.7 M (-0.13 %) |
Mar 17 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.47 | 12,500 | 30,875 | 9,673,920 | 9.7 M to 9.7 M (-0.13 %) |
Mar 17 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.37 | 12,500 | 29,625 | 9,686,420 | 9.7 M to 9.7 M (-0.13 %) |
Mar 21 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.95 | 2,100 | 4,095 | 9,621,820 | 9.6 M to 9.6 M (-0.02 %) |
Mar 21 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.01 | 12,500 | 25,125 | 9,623,920 | 9.6 M to 9.6 M (-0.13 %) |
Mar 21 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.19 | 12,500 | 27,375 | 9,636,420 | 9.6 M to 9.6 M (-0.13 %) |
Mar 21 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.29 | 12,500 | 28,625 | 9,648,920 | 9.7 M to 9.6 M (-0.13 %) |
Mar 12 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.30 | 12,500 | 28,750 | 9,698,920 | 9.7 M to 9.7 M (-0.13 %) |
Mar 12 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.31 | 12,500 | 28,875 | 9,711,420 | 9.7 M to 9.7 M (-0.13 %) |
Mar 12 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.37 | 12,500 | 29,625 | 9,723,920 | 9.7 M to 9.7 M (-0.13 %) |
Mar 10 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.43 | 12,500 | 30,375 | 9,736,420 | 9.7 M to 9.7 M (-0.13 %) |
Mar 10 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.45 | 12,500 | 30,625 | 9,748,920 | 9.8 M to 9.7 M (-0.13 %) |
Mar 10 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.43 | 12,500 | 30,375 | 9,736,420 | 9.7 M to 9.7 M (-0.13 %) |
Mar 10 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.45 | 12,500 | 30,625 | 9,748,920 | 9.8 M to 9.7 M (-0.13 %) |
Feb 28 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.51 | 12,500 | 31,375 | 9,786,420 | 9.8 M to 9.8 M (-0.13 %) |
Feb 28 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.37 | 12,500 | 29,625 | 9,798,920 | 9.8 M to 9.8 M (-0.13 %) |